Tag Archives: Roche

Is a Swine Flu Vaccine Backlash on the Cards?

By Julian Upton | Published: July 23, 2009
Image by The Artifex via Flickr The risk of over-production has paid off: world orders for swine vaccines will see billions of dollars in extra revenue for the biggest pharma companies. GlaxoSmithKline, Roche, Sanofi-Aventis, Novartis, and Baxter are all expected to report very healthy first-half earnings as a result of a wealth of government contracts for [...]
Posted in Global, News | Also tagged , , , , , , | 1 Comment

Phony Tamiflu Sites Spike in Wake of Swine Flu

By George Koroneos | Published: May 27, 2009
In the wake of the swine flu craze, at least 55 Web sites have sprung up in the last few weeks selling Tamiflu. That’s according to a new report by data firm MarkMonitor. Two of the pharmacies are certified—one in the US and one in the UK—and six of the pharmacies are actually using the [...]
Posted in Safety | Also tagged , , , , , | 2 Comments

M&A Round-up • 3/25/2009

By George Koroneos | Published: March 25, 2009
The latest round of merger and acquisition activities courtesy of our friends at Pharm Exec Europe: • Just days after its purchase of Genentech, Roche has made another acquisition, albeit a much smaller one, of the German firm Innovatis. Roche will pay EUR 15 million for the cell analytics company. • Oxford Gene Technology (OGT) is to [...]
Posted in Deals | Also tagged , , , , , , , , , | Leave a comment

Roche and Genentech Seal the Deal
for $46.8 Billion

By George Koroneos | Published: March 12, 2009
After months and months of back and forth over the true value of Genentech, Roche finally got the good news it’s been looking for: Genentech’s board of directors, this morning, approved Roche’s latest offer of $46.8 billion ($95 per share) to acquire all shares of the biotech giant. Roche plans to keep the Genentech site in [...]
Posted in Biotech | Also tagged , , , , , | 1 Comment

JP Morgan Healthcare Conference:
It’s All About "Money…Rather the Economy!"

By Audrey Erbes | Published: January 15, 2009
JP Morgan’s Healthcare Conference has always been about financing, but money has never been the main focus like it is at this year’s annual gathering in San Francisco. The hallmark of this investment meeting has been innovation, with companies passionately pitching their new product or technology and management team’s capability to execute on a [...]
Posted in Events | Also tagged , , , , , , , , , , , | 1 Comment